Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world data on T-DM1 efficacy - results of a single-center retrospective study of HER2-positive breast cancer patients.
Hardy-Werbin M, Quiroga V, Cirauqui B, Romeo M, Felip E, Teruel I, Garcia JJ, Erasun C, España S, Cucurull M, Montprade E, Pardo JC, Carballo D, Velarde JM, Margeli M. Hardy-Werbin M, et al. Among authors: felip e. Sci Rep. 2019 Sep 4;9(1):12760. doi: 10.1038/s41598-019-49251-5. Sci Rep. 2019. PMID: 31484985 Free PMC article. Clinical Trial.
Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy.
Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Margelí M, Ballana E. Castellví M, et al. Among authors: felip e. Cancers (Basel). 2020 Mar 18;12(3):713. doi: 10.3390/cancers12030713. Cancers (Basel). 2020. PMID: 32197329 Free PMC article.
Erratum: Castellví, M. et al. Pharmacological Modulation of SAMHD1 Activity by CDK4/6 Inhibitors Improves Anticancer Therapy. Cancers 2020, 12, 713.
Castellví M, Felip E, Ezeonwumelu IJ, Badia R, Garcia-Vidal E, Pujantell M, Gutiérrez-Chamorro L, Teruel I, Martínez-Cardús A, Clotet B, Riveira-Muñoz E, Margelí M, Esté JA, Ballana E. Castellví M, et al. Among authors: felip e. Cancers (Basel). 2020 Jun 29;12(7):1728. doi: 10.3390/cancers12071728. Cancers (Basel). 2020. PMID: 32610575 Free PMC article.
New Drugs, Old Toxicities: Pneumonitis Related to Palbociclib - A Case Report.
Felip E, Llobera L, Perez-Mañá C, Quintela D, Guasch I, Margelí M, Teruel I, Cirauqui B, Centeno C, Romeo M, Ballana E, Quiroga V. Felip E, et al. Breast Care (Basel). 2020 Oct;15(5):548-552. doi: 10.1159/000504618. Epub 2019 Dec 18. Breast Care (Basel). 2020. PMID: 33224001 Free PMC article.
Role of ctDNA in Breast Cancer.
Sant M, Bernat-Peguera A, Felip E, Margelí M. Sant M, et al. Among authors: felip e. Cancers (Basel). 2022 Jan 9;14(2):310. doi: 10.3390/cancers14020310. Cancers (Basel). 2022. PMID: 35053474 Free PMC article. Review.
Modulation of DNA Damage Response by SAM and HD Domain Containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) Determines Prognosis and Treatment Efficacy in Different Solid Tumor Types.
Felip E, Gutiérrez-Chamorro L, Gómez M, Garcia-Vidal E, Romeo M, Morán T, Layos L, Pérez-Roca L, Riveira-Muñoz E, Clotet B, Fernandez PL, Mesía R, Martínez-Cardús A, Ballana E, Margelí M. Felip E, et al. Cancers (Basel). 2022 Jan 27;14(3):641. doi: 10.3390/cancers14030641. Cancers (Basel). 2022. PMID: 35158911 Free PMC article.
Conventional and digital Ki67 evaluation and their correlation with molecular prognosis and morphological parameters in luminal breast cancer.
Pons L, Hernández-León L, Altaleb A, Ussene E, Iglesias R, Castillo A, Rodríguez-Martínez P, Castella E, Quiroga V, Felip E, Cirauqui B, Margelí M, Fernández PL. Pons L, et al. Among authors: felip e. Sci Rep. 2022 May 17;12(1):8176. doi: 10.1038/s41598-022-11411-5. Sci Rep. 2022. PMID: 35581229 Free PMC article.
545 results